Skip to main content

Table 7 Incidence rate per 100,000 person-year of other adverse events

From: Baseline incidence of meningitis, malaria, mortality and other health outcomes in infants and young sub-Saharan African children prior to the introduction of the RTS,S/AS01E malaria vaccine

Overall (N = 6897) Incidence rate per 100,000 person-years
n Person-years Value (95% CI)
Anemia 69 1490 4632 (3604, 5862)
Bacterial Infection 1 1492 67 (2, 373)
Burns 2 1492 134 (16, 484)
Conjunctivitis 1 1492 67 (2, 373)
Gastroenteritis 41 1491 2751 (1974, 3732)
Helminthic infection 2 1492 134 (16, 484)
Lower respiratory tract infection 38 1491 2549 (1804, 3499)
Malnutrition 3 1492 201 (41, 588)
Sepsis 22 1491 1475 (925, 2234)
Skin Infection 3 1492 201 (41, 588)
Upper respiratory tract infection 19 1492 1274 (767, 1989)
Urinary tract Infection 0 1492 0 (0, 247)
  1. According-to-protocol cohort, 5 to 17 months age-group. Other adverse events, AE other than AESI, meningitis or malaria that was diagnosed during hospitalization.
  2. Preferred terms of other AEs leading to hospitalization were grouped into medically relevant categories (refer to Additional file 5 for more details) for the calculation on the incidence rates. N, Number of study participants at risk within 30 days after each dose of the virtual primary vaccination schedule censored at the next dose; n, number of cases reported during that follow-up period
  3. CI: confidence interval; M: Months; ATP: According-to-protocol cohort